Medicines in the making
Institutions supported
Companies launched
Medicines in the clinic
Licenses to pharma
In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.
Learn MoreOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See all discoveries
More than 150 drug discovery projects now supported by Harrington Discovery Institute
Continue Reading
Understanding Alzheimer’s remains the scientific challenge of our generation. Seeing a challenge and unmet need, Alzheimer’s researchers supported by Harrington Discovery Institute are attacking the disease in novel ways, with some early successes.
Continue Reading
More than 150 drug discovery projects now supported by Harrington Discovery Institute
Continue Reading
Dr. Tang, Stanford University, Harrington Scholar, is developing patidegib, a therapry that will hopefully be the first topical drug that is safe and efficacious for Basal Cell Carcinoma (BCC) tumors (skin cancer) prevention.
Continue Reading